Literature DB >> 23408250

Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts".

John F Wyman1, Eric S Lavins, David Engelhart, Erica J Armstrong, Kimberly D Snell, Paul D Boggs, Shaena M Taylor, Rindi N Norris, Frank P Miller.   

Abstract

3,4-Methylenedioxypyrovalerone (MDPV) is a psychoactive, synthetic analog of the central nervous system stimulant cathinone. Its recent popularity as a recreational drug in the United States has led to numerous reports to poison control centers across the country. As with other synthetic cathinones, the recreational use of MDPV has resulted in death. MDPV is thought to exert its pharmacologic effects by inhibiting the reuptake of dopamine and norepinephrine. This report describes the case of an exposure of a 39-year-old male to MDPV, which resulted in his death. Postmortem concentrations of MDPV in various tissues were measured. The detection of MDPV in tissues and fluids was accomplished using gas chromatography-mass spectrometry analysis after solid-phase extraction. Blood analysis also demonstrated therapeutic levels of lamotrigine, fluoxetine, risperidone, benztropine, pseudoephedrine and ibuprofen. The detection of cathinones in hair was conducted using high-performance liquid chromatography-tandem mass spectrometry after solid-phase extraction. MDPV was uniformly distributed among multiple tissues (blood, brain, muscle, cerebrospinal fluid and lung) at concentrations of approximately 0.4 to 0.6 µg/mL. Tissue and fluids responsible for detoxification/excretion had higher concentrations of MDPV (kidney, liver and bile > 0.8 µg/mL). A blood concentration ≥ 0.4 µg/mL was judged sufficient to cause death. The cause of death was ruled MDPV intoxication resulting in cardiac arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408250     DOI: 10.1093/jat/bkt001

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  33 in total

1.  Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.

Authors:  Kayla N Ellefsen; Sébastien Anizan; Marisol S Castaneto; Nathalie A Desrosiers; Thomas M Martin; Kevin L Klette; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-03-21       Impact factor: 3.345

Review 2.  Baths salts, spice, and related designer drugs: the science behind the headlines.

Authors:  Michael H Baumann; Ernesto Solis; Lucas R Watterson; Julie A Marusich; William E Fantegrossi; Jenny L Wiley
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

3.  The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland.

Authors:  Pirkko Kriikku; Janne Rintatalo; Katja Pihlainen; Jukka Hurme; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2015-04-02       Impact factor: 2.686

4.  Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats.

Authors:  S M Aarde; P K Huang; T J Dickerson; M A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2014-11-26       Impact factor: 4.530

5.  Monoaminergic toxicity induced by cathinone phthalimide: An in vitro study.

Authors:  Susan M Lantz; Hector Rosas-Hernandez; Elvis Cuevas; Bonnie Robinson; Kenner C Rice; William E Fantegrossi; Syed Z Imam; Merle G Paule; Syed F Ali
Journal:  Neurosci Lett       Date:  2017-07-03       Impact factor: 3.046

6.  Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.

Authors:  Aparna Shekar; Jenny I Aguilar; Greta Galli; Nicholas V Cozzi; Simon D Brandt; Arnold E Ruoho; Michael H Baumann; Heinrich J G Matthies; Aurelio Galli
Journal:  J Chem Neuroanat       Date:  2017-02-03       Impact factor: 3.052

Review 7.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 8.  A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature.

Authors:  Brigitte Desharnais; Yann Dazé; Laura M Huppertz; Pascal Mireault; Cameron D Skinner
Journal:  Forensic Sci Med Pathol       Date:  2017-07-01       Impact factor: 2.007

9.  Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.

Authors:  Justin L Poklis; Kelly G Devers; Elise F Arbefeville; Julia M Pearson; Eric Houston; Alphonse Poklis
Journal:  Forensic Sci Int       Date:  2013-10-18       Impact factor: 2.395

10.  In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Ana Margarida Araújo; Márcia Carvalho; Vera Marisa Costa; José Alberto Duarte; Ricardo Jorge Dinis-Oliveira; Maria de Lourdes Bastos; Paula Guedes de Pinho; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-11-19       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.